WITH BIG NEW FROM PRESIDENT BIDEN THIS WEEK SUPPLYING OVER 500 MILLION VACCINES AROUND THE WORLD. PFIZER LOOKS READY FOR ITS NEXT BULL RUN, WITH A PERFECT ENTRY BUY CANDLE ON THE WEEKLY TIMEFRAME.
THE BIG LONG! Vaccine for the Covid-Mutants! :-)
ENTRY: 44.20 EUR
TARGET: 90.00 EUR (104 % profit)
STOP: 32.40 EUR
- This is only an interim analysis result of the CUREVAC Covid vaccince!!
- Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues.
- The vaccine candidate is in the final...
Top Indicator: Laguerre RSI
Bottom Indicator: Tradingview MACD
Here is a pattern based off of Fractals. We have a divergence in the MACD and two big trendlines coming into play.
We could see a big move either way here, price has been hanging out after a solid move up and the dips are getting bought but we haven't broken out yet.
Seeing a Volatility Contraction Pattern (VCP) from the 3 hour time frame with a Parabolic SAR switching below the candles. I'm very bullish on OCGN since during the April 30th overall market bearishness, OCGN holds its place and is the only green candle in my watchlist. Another thing to look is from the weekly time frame which in my technical analysis using the...
MRNA has had a few wild weeks going up from $120 to $170.
I believe this could be the end of the bullishness and it may do a correction.
Why do I believe this could happen?
MRNA hit historic resistance of $170, after hitting that mark it began dropping. This resistance seems like it can hold.
RSI is bounced off the 70 mark on the daily chart.
I love JNJ long and believe that they are going to be fine with the recent COVID-related dip.
Their vaccine could do more damage than AstraZeneca's and governments will still buy it in order to herd the sheep.
You need to understand that JNJ is so much more than a vaccine company.
Expect this stock to go back up to the $167 level, as well as breaking the $170...
MRNA seems to have entered another downward channel trend.
Using the previous resistance on the last downward channel trend we can see it can act as a sort of support, the trend also made two other downward resistances as you can see on the chart.
This makes me to believe that this could go back down to $120 where it can make a double bottom which can be a great...
As of Jan '21, the US Dollar 💵 had one of the most crowded trades in the world. Since then, higher US YIELDS have forced banks and hedge funds to unwind more than $25 billion in the short trade.
However, the DXY...
On PFIZER , H1 timeframe price is around a critical decision zone, so what can we expect here:
1. Global Recover: If the fundamentals are positive, then the chart will be bullish and we will go into the 1st scenario where price continues to trade inside the channel until it reaches the resistance zone were we can look for sell setups.
2. Failure: Unlike the...
In my work, I always try to combine fundamental analysis and technical analysis.
They are both important, especially on a topic as important as the covid vaccine.
Johnson & Johnson is about to be marketed, after the approval of the EMA on 11 March.
Exactly after the announcement, I bought the stock.
The JnJ vaccine has a much lower distribution cost than Pfizer...
I picked up some Lockheed Martin today, because both value and sentiment on the stock are looking too good to resist.
I estimate Lockheed's forward P/E at about 12.5, which is really cheap for a megacap. Forward P/S is 1.5, and forward dividend yield is over 3%. I estimate Lockheed's PEG ratio at about 2, with the annual earnings growth rate sitting near...
· Current Price – $0.0419
· Best Case Scenario PT over 1$
· Market Cap – $11 million
· Debt – 0
Are a biomedical company with a clear aim to revolutionize the world of medicine. They are working towards a creation of variety of antibodies and treatments using extracorporeal techniques (outside of body). They believe they have the...